Avalyn Pharma News, Avalyn Pharma Quote, AVLN Quote

Avalyn Pharma (NQ:AVLN) Delayed: 28.30 +2.62 (10.20%)

Prev. Close

$25.68

Today 6M 1Y 5Y

Open

$25.25

52 Wk High

$0.00

52 Wk Low

$0.00

Day High

$29.27

Day Low

$24.90

P/E

N/A

EPS

$0.00

Volume

364,052

Friends, Peers and Foes (?): AKTS, UCB UCBJY (more...)

ALERTS | RSS

Jul 1, 2026 05:21 PM Form 8-K Avalyn Pharma Inc. For: Jun 29
Jun 17, 2026 08:03 AM Form 8-K Avalyn Pharma Inc. For: Jun 17
Jun 17, 2026 08:00 AM Avalyn completes enrollment in Phase 2b trial of inhaled pirfenidone
Jun 17, 2026 08:00 AM Avalyn Completes Target Enrollment in Phase 2b MIST Trial of AP01 (Inhaled Pirfenidone) for Patients with Progressive Pulmonary Fibrosis
Jun 3, 2026 08:01 AM Form 10-Q Avalyn Pharma Inc. For: Mar 31
Jun 3, 2026 07:25 AM Form 8-K Avalyn Pharma Inc. For: Jun 03
Jun 3, 2026 07:00 AM Avalyn Reports First Quarter 2026 Financial Results and Recent Business Highlights
May 27, 2026 08:00 AM Avalyn to Participate in the Jefferies Global Healthcare Conference
May 26, 2026 07:41 AM Evercore ISI Starts Avalyn Pharma (AVLN) at Outperform
May 26, 2026 12:54 AM Morgan Stanley Starts Avalyn Pharma (AVLN) at Overweight

Entities mentioned with AVLN

View All Entities